[badge class=”bumpup” bgcolor=”#1e73be” value=”For healthcare professionals” float_right=”true”]

International Guidelines for the Management of ADHD
[panel style=”panel-default”]
[panel-header]
American Academy of Child and Adolescent Psychiatry (AACAP)
[/panel-header]
[panel-content]

The AACAP’s Practice Parameters for the Assessment and Treatment of Children and Adolescents with Attention-Deficit / Hyperactivity Disorder describes the assessment and treatment of children with ADHD based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacological and psychosocial interventions for ADHD.

[HTML] [PDF]
[/panel-content]
[/panel]

[panel style=”panel-default”]
[panel-header]
American Academy of Pediatrics (AAP)
[/panel-header]
[panel-content]

The AAP’s Guidelines “Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder” was developed by the AAP’s Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder, with Technical Resources International in Washington DC and under the auspices of the U.S. Agency for Healthcare Research and Quality. This guideline is intended for use by clinicians working in primary care settings. [Also see: AAP Process of Care Algorithm — Implementing the Key Action Statements: An Algorithm and Explanation for Process of Care for the Evaluation, Diagnosis, Treatment, and Monitoring of ADHD in Children and Adolescents]

[HTML]  [PDF]
[/panel-content]
[/panel]

[panel style=”panel-default”]
[panel-header]
National Institute for Health and Clinical Excellence (NICE)
[/panel-header]
[panel-content]

The NICE Guidelines “Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults” were developed by two UK organizations: the National Institute for Health and Clinical Excellence and the National Collaborating Centre for Mental Health and published in 2009.

[HTML] [PDF]
[/panel-content]
[/panel]

[panel style=”panel-default”]
[panel-header]
Canadian ADHD Practice Guidelines (CAP)
[/panel-header]
[panel-content]

Canadian ADHD Resource Alliance (CADDRA) published CAP third edition. CADDRA ADHD Practice Guidelines, including all necessary forms and scales, is available online [www.caddra.ca] and can be downloaded in full or as individual chapters and forms in PDF format.

[HTML] [PDF]
[/panel-content]
[/panel]

[panel style=”panel-default”]
[panel-header]
Australian Guidelines on ADHD
[/panel-header]
[panel-content]

The Australian draft guidelines on attention deficit hyperactivity disorder, developed by the Royal Australasian College of Physicians.

“These draft Australian Guidelines on ADHD were completed in 2009 . Despite ongoing research during the intervening years and release of a new edition of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, the RACP believes that these Guidelines remain relevant and provide health professionals with a guide to assessment, management and care of preschoolers, children, adolescents and adults with ADHD.”

[HTML] [PDF]
[/panel-content]
[/panel]

[panel style=”panel-default”]
[panel-header]
Spanish Guidelines on ADHD
[/panel-header]
[panel-content]

This Clinical Practice Guideline on Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents aims to give citizens, health and education professionals, a useful instrument that will provide answers to the basic questions about the disorder, especially those related to the diagnostic assessment and the different types of treatment of ADHD in children and adolescents.

[HTML] [PDF]
[/panel-content]
[/panel]

[panel style=”panel-default”]
[panel-header]
Scottish Guidelines on ADHD
[/panel-header]
[panel-content]

Children with ADHD/HKD and their families require a comprehensive package of care, involving education services as well as health. This guideline aims to provide a framework for evidence based assessment and management of ADHD/HKD which can be applied within a local multidisciplinary and multiagency approach.

[HTML] [PDF]
[/panel-content]
[/panel]

 

  

Updated: 15 February 2016 by Jeremy Varnham